Logo wahanariau.com
  2. Samsung bioepis

Samsung bioepis

Index
Globenewswire

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

Jumat, 10 Januari 2025 - 21:00:00 Wib
Globenewswire

Kyung-Ah Kim Named as President and Chief Executive Officer of Samsung Bioepis

Rabu, 27 November 2024 - 13:00:00 Wib
Globenewswire

Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D Innovation

Selasa, 25 Juni 2024 - 21:28:19 Wib
Globenewswire

Samsung Bioepis Initiates Phase 3 Clinical Trial for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)

Sabtu, 06 April 2024 - 23:02:47 Wib
Globenewswire

Samsung Bioepis Partners with Sandoz to Commercialize Ustekinumab Biosimilar Candidate

Senin, 11 September 2023 - 22:00:00 Wib
Globenewswire

Samsung Bioepis Releases 2023 Sustainability Report

Kamis, 29 Juni 2023 - 22:00:00 Wib